Estimated impact of fezolinetant versus placebo on work productivity and indirect costs among women experiencing vasomotor symptoms associated with menopause. Journal Abstract - Guideline Central

Estimated impact of fezolinetant versus placebo on work productivity and indirect costs among women experiencing vasomotor symptoms associated with menopause.

Published: 2026 Mar 31

Authors

, , , , , , ,

Abstract

This study evaluated the impact of fezolinetant versus placebo on work productivity and indirect costs among women with moderate to severe vasomotor symptoms (VMS) associated with menopause in seven countries.

Keywords: Absenteeism, Change of life, Economics, Hot flashes, Presenteeism.

Source

Menopause (New York, N.Y.)

Publication Type

Journal Article

Language

English

PubMed ID

41915440

You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.